Licensed RSV Vaccine

BIOLOGICAL2 trials

Sponsors

Icosavax, Inc., Sanofi Pasteur, a Sanofi Company

Conditions

Healthy ParticipantsHuman Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization

Phase 1

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Active, not recruitingNCT06686654

Sanofi Pasteur, a Sanofi CompanyHuman Metapneumovirus Immunization, Respiratory Syncytial Virus Immunization

Start: 2024-11-11End: 2027-01-18Updated: 2025-12-11

Phase 2

A Study of IVX-A12 in Adults Participants

CompletedNCT06481579

Icosavax, Inc.Healthy Participants

Start: 2024-06-10End: 2024-12-19Updated: 2025-08-26